These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24927824)

  • 1. cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications.
    Hoffmann LS; Chen HH
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Aug; 387(8):707-18. PubMed ID: 24927824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From bedside to bench--meeting report of the 7th International Conference on cGMP "cGMP: generators, effectors and therapeutic implications" in Trier, Germany, from June 19th to 21st 2015.
    Friebe A; Sandner P; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Dec; 388(12):1237-46. PubMed ID: 26486926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report.
    Friebe A; Kraehling JR; Russwurm M; Sandner P; Schmidtko A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1669-1686. PubMed ID: 37079081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cGMP in heart failure: a new therapeutic paradigm.
    Boerrigter G; Lapp H; Burnett JC
    Handb Exp Pharmacol; 2009; (191):485-506. PubMed ID: 19089342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
    Hamad AM; Range S; Holland E; Knox AJ
    Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGMP becomes a drug target.
    Schlossmann J; Schinner E
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Mar; 385(3):243-52. PubMed ID: 22297800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting report of the 8
    Friebe A; Sandner P; Schmidtko A
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1177-1188. PubMed ID: 29018913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Endothelium-Dependent Nitric Oxide-cGMP Pathway.
    Mónica FZ; Bian K; Murad F
    Adv Pharmacol; 2016; 77():1-27. PubMed ID: 27451093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relaxation induced by uroguanylin and the expression of natriuretic peptide receptors in human corpora cavernosa.
    Sousa CM; Havt A; Santos CF; Arnaud-Batista FJ; Cunha KM; Cerqueira JB; Fonteles MC; Nascimento NR
    J Sex Med; 2010 Nov; 7(11):3610-9. PubMed ID: 20102442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
    Castro LR; Schittl J; Fischmeister R
    Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structure, regulation and functions of particulate guanylyl cyclase type A].
    Mitkiewicz M
    Postepy Hig Med Dosw (Online); 2015 Apr; 69():457-68. PubMed ID: 25897107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and regulation of soluble guanylate cyclase.
    Derbyshire ER; Marletta MA
    Annu Rev Biochem; 2012; 81():533-59. PubMed ID: 22404633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ENaC is regulated by natriuretic peptide receptor-dependent cGMP signaling.
    Guo LJ; Alli AA; Eaton DC; Bao HF
    Am J Physiol Renal Physiol; 2013 Apr; 304(7):F930-7. PubMed ID: 23324181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
    Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
    Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes.
    Geng Y; Zhou L; Thompson WJ; Lotz M
    J Biol Chem; 1998 Oct; 273(42):27484-91. PubMed ID: 9765278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation.
    Bice JS; Burley DS; Baxter GF
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):269-82. PubMed ID: 24572031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Handbook of Experimental Pharmacology 191. cGMP: generators, effectors and therapeutic implications. Preface.
    Schmidt HH; Hofmann F; Stasch JP
    Handb Exp Pharmacol; 2009; (191):v-vi. PubMed ID: 19192509
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiplicity of Nitric Oxide and Natriuretic Peptide Signaling in Heart Failure.
    Preedy MEJ; Baliga RS; Hobbs AJ
    J Cardiovasc Pharmacol; 2020 May; 75(5):370-384. PubMed ID: 31498237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-type natriuretic peptide-induced relaxation through cGMP-dependent protein kinase and SERCA activation is impaired in two kidney-one clip rat aorta.
    Pernomian L; do Prado AF; Silva BR; de Paula TD; Grando MD; Bendhack LM
    Life Sci; 2021 May; 272():119223. PubMed ID: 33610574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.
    Chen CN; Watson G; Zhao L
    Vascul Pharmacol; 2013 Mar; 58(3):211-8. PubMed ID: 22982057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.